SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
|
Aldeyra Therapeutics, Inc.
|
|
(Name of Issuer)
|
|
Common Stock, $0.001 par value
|
|
(Title of Class of Securities)
|
|
01438T106
|
|
(CUSIP Number)
|
|
December 31, 2019
|
|
Date of Event Which Requires Filing of this Statement
|
Check the appropriate box to designate the rule pursuant to which this Schedule is Filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
_______________________
1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
1
CUSIP No. 01438T106
|
1)
|
Name of Reporting Person
I.R.S. Identification No. of Above Person (Entities Only) (Voluntary)
Domain Partners VI, L.P.
|
||
|
2)
|
Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
|
||
|
3)
|
SEC Use Only
|
||
|
4)
|
Citizenship or Place of Organization
Delaware
|
||
|
Number of
Shares Beneficially
Owned by Each
Reporting Person
With
|
5)
|
Sole Voting Power
1,877,091 shares of Common Stock *
|
|
|
6)
|
Shared Voting Power
-0-
|
||
|
7)
|
Sole Dispositive Power
1,877,091 shares of Common Stock *
|
||
|
8)
|
Shared Dispositive Power
-0-
|
||
|
9)
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,877,091 shares of Common Stock *
|
||
|
10)
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
|
||
|
11)
|
Percent of Class Represented by Amount in Row (9)
6.7% **
|
||
|
12)
|
Type of Reporting Person
PN
|
||
* As of December 31, 2019.
** Based on 27,952,937 shares of Common Stock outstanding as of November 7, 2019, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2019 filed with the Securities and Exchange Commission on
November 7, 2019.
2
CUSIP No. 01438T106
|
1)
|
Name of Reporting Person
I.R.S. Identification No. of Above Person (Entities Only) (Voluntary)
DP VI Associates, L.P.
|
||
|
2)
|
Check the Appropriate Box if a Member of a Group
(a) [X]
(b) [ ]
|
||
|
3)
|
SEC Use Only
|
||
|
4)
|
Citizenship or Place of Organization
Delaware
|
||
|
Number of
Shares Beneficially
Owned by Each
Reporting Person
With
|
5)
|
Sole Voting Power
8,763 shares of Common Stock *
|
|
|
6)
|
Shared Voting Power
-0-
|
||
|
7)
|
Sole Dispositive Power
8,763 shares of Common Stock *
|
||
|
8)
|
Shared Dispositive Power
-0-
|
||
|
9)
|
Aggregate Amount Beneficially Owned by Each Reporting Person
8,763 shares of Common Stock *
|
||
|
10)
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
|
||
|
11)
|
Percent of Class Represented by Amount in Row (9)
Less than 0.1% **
|
||
|
12)
|
Type of Reporting Person
PN
|
||
* As of December 31, 2019.
** Based on 27,952,937 shares of Common Stock outstanding as of November 7, 2019, as reported in the Issuer’s Report on Form 10-Q for the period ended September 30, 2019 filed with the Securities and Exchange Commission on
November 7, 2019.
3
CUSIP No. 01438T106
Amendment No. 1 to Schedule 13G
Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons on February 5, 2015 (the “Schedule 13G”). Terms defined in the Schedule 13G are used
herein as so defined.
The following items of the Schedule 13G are hereby amended and restated as follows:
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
131 Hartwell Avenue, Suite 320, Lexington, MA 02421
|
|
Item 2(b)
|
Address of Principal Business Office:
202 Carnegie Center, Suite 104, Princeton, NJ 08540
|
|
Item 4
|
Ownership
|
|
(a) through (c):
The information requested in these paragraphs is incorporated herein by reference to the cover pages to this Amendment No. 1 to Schedule 13G. In addition, as of December 31, 2019, Domain Associates, LLC, an
affiliate and the investment manager of the Reporting Persons, directly beneficially owned 10,358 shares of Common Stock, or less than 0.1% of the Common Stock outstanding.
|
|
4
CUSIP No. 01438T106
SIGNATURE
After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned hereby certifies that the information set forth in this statement is true, complete and correct.
Dated: January 9, 2020
|
DOMAIN PARTNERS VI, L.P.
|
|||
|
By:
|
One Palmer Square Associates VI, L.L.C., General Partner
|
||
|
By:
|
/s/ Lisa A. Kraeutler
|
||
|
Attorney-in-Fact
|
|||
|
DP VI ASSOCIATES, L.P.
|
|||
|
By:
|
One Palmer Square Associates VI, L.L.C., General Partner
|
||
|
By:
|
/s/ Lisa A. Kraeutler
|
||
|
Attorney-in-Fact
|
|||
5